Skip to main content
Interactive Cardiovascular and Thoracic Surgery logoLink to Interactive Cardiovascular and Thoracic Surgery
. 2012 Mar 28;15(1):129–135. doi: 10.1093/icvts/ivs070

Is a tricuspid annuloplasty ring significantly better than a De Vega's annuloplasty stitch when repairing severe tricuspid regurgitation?

Maziar Khorsandi a, Amit Banerjee b, Harpreet Singh b, Aseem R Srivastava c,*
PMCID: PMC3380971  PMID: 22457189

Abstract

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether tricuspid valve (TV) repair with an annuloplasty ring leads to an improved outcome over a conventional suture annuloplasty for patients with severe tricuspid incompetence. Altogether, 306 papers were found using the reported search, of which 14 presented the best evidence to answer the clinical question. The author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these papers are tabulated. We found seven studies supporting the use of ring annuloplasty over De Vega's suture annuloplasty. Five studies found no significant difference in outcome between the two techniques. We found only two studies supporting the use of De Vega's suture annuloplasty over ring annuloplasty. Therefore, most of the tabulated studies show good evidence in support of ring annuloplasty compared with De Vega's suture repair for treatment of moderate to severe TV regurgitation. One cohort study identified a 20.4% postoperative failure rate for tricuspid regurgitation (TR) repair and concluded non-application of ring as a predictor for reoperation. One cohort study with a mean follow-up of 17 months reported success rates as high as 97% with ring annuloplasty for TV regurgitation. One large cohort study of 2277 patients with TR who had undergone repair reported a sustained reduction in TR and the rate of recurrence in a 5-year echocardiographic follow-up. One cohort study of 129 patients concluded that ring annuloplasty has the lowest rate of recurrence compared with De Vega's suture repair. An old randomized controlled trial (RCT) on the subject also reported a similar result to the mentioned studies. In contrast, we reviewed one recent study and four older studies and found no significant difference between the two techniques. We reviewed one study that reported De Vega's suture repair as a superior technique to ring annuloplasty. We conclude that there is good evidence supporting ring annuloplasty over conventional De Vega's suture annuloplasty.

Keywords: Tricuspid valve, Suture, Cardiac valve annuloplasty

INTRODUCTION

A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1].

CLINICAL SCENARIO

You are planning mitral valve repair on a 35-year old patient with severe mitral incompetence. He also has severe tricuspid regurgitation (TR) on echocardiography. It is your usual practice to perform a De Vega's suture tricuspid annuloplasty under these circumstances. However, a colleague tells you that, in his experience, people have now mostly moved away from suture annuloplasty towards commercially available annuloplasty rings as they are better. You decide to check the literature before switching to the more expensive option.

THREE-PART QUESTION

In [patients with severe tricuspid incompetence] does [repair with an annuloplasty ring] compared with [De Vega's annuloplasty suture] improve [tricuspid valve competence].

SEARCH STRATEGY

Medline was searched from 1948 to November week 1, 2011, using the OVIDSP interface (tricuspid valve$.mp) AND (exp Cardiac Valve Annuloplasty/OR annuloplasty.mp. OR de vega$.mp.) AND (thoracic surgery.mp. or exp Thoracic Surgery/OR exp Cardiac Surgical Procedures/OR valve surgery.mp.).

SEARCH OUTCOME

Three hundred and six papers were identified from the search strategy from which 14 represented the best evidence on this topic and are summarized in Table 1.

Table 1:

Summary of best evidence papers

Author, date and country, Study type (level of evidence) Patient group Outcomes Key results Comments
Bernal et al. (2010), Circulation, Spain [2]

Retrospective cohort study
(level 3)
153 consecutive patients underwent TV repair for rheumatic valvular disease. The repair techniques included flexible ring annuloplasty in 68 (44%), suture annuloplasty in 20 (13.1%) combined with tricuspid commissurotomy in 62 (42.5%)

The mean follow-up was 15.8 years
Rate of reoperation De Vega's suture repair vs. ring annuloplasty 63 (40%) of patients required reoperation. Reoperation was associated significantly with the method of valve repair

De Vega's annuloplasty was associated with significantly higher rates of reoperation than ring annuloplasty
The number of subjects is a limiting factor for this study. This study focuses on rheumatic valvular disease, the incidence of which is very few in the western world nowadays
 
Giamberti et al. (2011), J Heart Valve Surg, Italy [3]

Retrospective cohort study
(level 3)
Total of 65 patients underwent TV repair for TR between 2000 and 2008. TR was repaired using suture annuloplasty (n = 48), valve ring (n = 14) and TV replacement (n = 3)

Mean follow-up period was 5 years
Comparison of outcome between De Vega's annuloplasty and ring repair for TR No significant difference seen in the outcome between annuloplasty and ring repair for TR at 5 years of follow-up The study is a retrospective one. The number of subjects studied was too few for the outcome to be significant. In particular, the number of patients undergoing ring repair was much fewer than the patients undergoing De Vega's annuloplasty
Tang et al. (2006), Circulation, Canada [4]

Prospective cohort study
(level 3)
1978–2003, 702 consecutive patients undergoing TV repair. Annuloplasty ring applied in 209 patients and 493 had De Vega's annuloplasty

Mean follow-up- 5.9 ± 4.9 years
Perioperative events








Survival




Recurrent TR


New York Heart Association (NYHA) class
Higher incidence of low cardiac output in patients receiving a ring (P = 0.001). However, similar incidence of perioperative deaths, myocardial infarction, bleeding, stroke and endocarditis

Better long-term (P = 0.007) and event-free (P = 0.01) survival in patients receiving a ring

Lower TR recurrence rate in patients. receiving a ring

NYHA class III/IV symptoms were reported in 20% of patients that underwent ring annuloplasty vs. 25% in patients who underwent suture annuloplasty
Significantly more patients in the no ring group had prior cardiac surgery (P = 0.001), coronary artery disease (P = 0.03) and endocarditis (P = 0.04). Also the mean age differed significantly between the groups (P = 0.001); these could account for poorer survival in the no ring group

Upon follow-up: In the ring group, 15% had no TR, 55% mild and 30% moderate to severe TR

In the no ring group, 10% had no TR, 54% mild, and 36% moderate to severe TR. These rather small differences are projected to 15 years when they achieve significance

Events registered for event-free survival thromboembolism, valve thromboembolism, structural valve dysfunction, bleeding event and endocarditis—these relate to prosthetic valves replaced concomitantly (80% mitral, 33% aortic) and not to TV repair per se. Only TV reoperation and valve-related mortality directly addresses the issue, none was significantly different between the groups

Cross clamp time was significantly higher (P = 0.049) in the ring group, cardiopulmonary bypass (CPB) time was similar (even though the no-ring group had significantly higher redo patients and more patients undergoing concomitant coronary artery bypass grafting). This is important as significantly higher percentage of patients undergoing ring annuloplasty suffered low cardiac output
 
McCarthy et al. (2004), J Thorac Cardiovasc Surg, USA [5]

Prospective cohort study
(level 3)
Between January 1990 and January 1999, 790 patients underwent annuloplasty for functional TR. 139 (17%) with Carpentier–Edwards (CE) semi-rigid ring, 291 (37%) with Cosgrove–Edwards flexible band, 116 (15%) De Vega and 243 (31%) Peri-Guard

Follow-up every 2 years and then cross-sectional in the year 2000
Durability of repair







Reoperation

Functional status

Survival
At 1 month, prevalence of 3+ or 4+ TR similar among all groups (15% Carpentier–Edwards semi-rigid ring, 15% with Cosgrove–Edwards band, 14% De Vega and 15% for Peri-Guard)

Severity of TR stable across time with Carpentier–Edwards ring (P = 0.7) and Cosgrove–Edwards band (P = 0.05). However, it rose rapidly with De Vega (P = 0.002) and Peri-Guard (P = 0.009)
Late worsening of TR is associated not only with patient factors but also by the type of annuloplasty. De Vega's and Peri-Guard annuloplasty showed considerable late worsening of TR

Important strength of the study is the large number of patients, routine predischarge echocardiography, and regular 2 yearly follow-up

Although the severity of TR was more stable across time with Carpentier–Edwards ring, when analysed individually. The difference in late worsening of TR between the two groups (De Vega's vs. CE ring) did not reach statistical significance (P = 0.06)

Survival, NYHA class, reoperation rates reported collectively. Relationship of these end points with an individual repair type is not reported
 
Rivera et al. (1985), J Thorac Cardiovasc Surg, Spain [6]

Randomized controlled trial
(level 2)
Between January 1977 and January 1980, 159 patients with moderate to severe TR were randomized to one of the two groups: Carpentier's (n = 76) and De Vega's (n = 83) tricuspid annuloplasty

Average follow-up was 65 months (range, 48–85 months)

76 patients underwent cardiac catheterization
In-hospital/late deaths



Reoperations

Clinical status at follow-up




Angiographic incidence of TR on follow–up
Similar incidence of early and late deaths between the two groups

Similar rates of reoperation

In patients who did not have a reoperation and who had no left heart lesion on cardiac catheterization—the incidence of murmur of TR and clinical signs of right heart failure were higher in patients that had undergone De Vega's annuloplasty as compared to patients that received a ring annuloplasty (14 of 41 and 4 of 40, respectively, P < 0.01)

In patients with peripheral vascular resistance (PVR) < 1000 dynes/s/cm5, moderate to severe TR was lower in patients who underwent Carpentier's ring annuloplasty compared with De Vega's annuloplasty (1 of 19 and 9 of 19, respectively, P < 0.01)
Carpentier's ring annuloplasty is more efficacious in controlling TR in patients with satisfactory left heart function

A good randomized study that provides reliable evidences in favour of ring annuloplasty

In patients with raised PVR and left heart lesions, the outcome of both techniques is equally unsatisfactory

Since this is an old study, echocardiography was not utilized in the assessment of any patient. 26 (16%) of the patients were assessed on clinical grounds alone and 9 (5.7%) by digital exploration by the surgeon before bypass. The remaining 124 (78%) patients were assessed by ventriculography
 
Ghoreishi et al. (2011), Ann Thorac Surg, USA [9]

Retrospective cohort study
(level 3)
101 patients between 2006 and 2009 underwent TV repair for moderate or severe TR. 88% of these patients had their TR treated with three-dimensional rigid annuloplasty ring

Mean follow-up was 17 ± 9 months
Efficacy of rigid, three-dimensional annuloplasty ring in the treatment of functional TR In this group of patients, the freedom rate from significant (moderate or severe) TR on discharge was 97%

The study concluded that three-dimensional annuloplasty ring repair is the method of choice for a reliable and durable treatment of functional TR
The number of patients in this study was a major limiting factor
 
Navia et al. (2010), J Thorac Cardiovasc Surg, USA [10]

Retrospective cohort study
(level 3)
2277 patients underwent TV repair for TR. The surgical methods utilized included. 1636 (71%) of the patients underwent ring annuloplasty. 129 (5.1%) underwent De Vega's suture annuloplasty. 185 (8.1%) patients underwent Peri-Guard annuloplasty

Echocardiographic follow-up period of 5 years
Comparison of efficacy of ring annuloplasty vs. De Vega's annuloplasty On 5-year follow-up, patients with ring annuloplasty alone had the least rate of TR compared with the other surgical techniques This was a large retrospective cohort study. However, the number of subjects included in each surgical technique was very variable for the comparison to be based on objective analysis e.g. 71% of patients had ring annuloplasty, whereas only 5.1% had undergone De Vega's suture repair
 
Sarralde et al. (2010), Ann Thorac Surg, Spain [11]

Retrospective cohort study
(level 3)
299 patients underwent TV repair between 1974 and 2007 for severe rheumatic valvular disease. Prosthetic ring annuloplasty was performed in 78 (26%) patients, commissurotomy and ring annuloplasty in 82 (27%), isolated commissurotomy in 10 (4%), suture annuloplasty in 105 (35%) and commissurotomy and suture annuloplasty in 24 (8%)

Mean follow-up was 16 years
The use of age, NYHA functional class and postclamping time were assessed as predictive factors for late mortality The study found a reduced rate of late mortality in the patient group who underwent De Vega's suture repair of the TV, compared with ring annuloplasty

Age, postclamping time and NYHA class were associated with long-term mortality
The study is of value due to long follow-up. Nevertheless, although the mean follow-up was of 16 years, some patients had had their procedures over 30 years prior to the date of publication. It was acknowledged that there had been a change in population as well as change in the operative techniques over the years which could be confounders affecting the study result
 
Basel et al. (2010), Heart Surg Forum, Turkey [12]

Retrospective cohort study
(level 3)
129 patients underwent annuloplasty to correct TV regurgitation between 2004 and 2008. The patients in this study were divided into two groups. Group 1 was the patients who had undergone ring annuloplasty (n = 67) and Group 2 had undergone De Vega's suture repair (n = 62) Complication and recurrence rates of ring annuloplasty vs. De Vega's suture repair Both groups had low complication and recurrence rates. However, patients in Group 1 had lower recurrence rates than those in Group 2 The number of patients is the limiting factor for this study
 
Matsuyama et al. (2001), J Heart Valve Dis, Japan [13]

Retrospective cohort study
(level 3)
Between January 1995 and July 2000, 45 patients who had undergone surgery for secondary TR were reviewed; 28 (62%) had undergone De Vega's annuloplasty and 17 (38%) had undergone CE ring annuloplasty TR recurrence in each group




NYHA class between the two groups
Significant difference in TR recurrence: 45% (13 of 28) in De Vega's and 6% (1 of 16) in Carpentier–Edwards ring annuloplasty

No significant difference in the NYHA class
CE ring annuloplasty is superior to De Vega's annuloplasty in patients with secondary TR

The sample size was too small in this study
 
 
 
Chang et al. (2008), Ann Thorac Surg, South Korea [14]

Retrospective cohort study
(level 3)
334 patients underwent tricuspid annuloplasty for functional TR between 1997 and 2006. De Vega's suture annuloplasty was performed in 117 and autologous pericardial strip annuloplasty was performed in 217 patients

Mean follow-up was 3.5 years
Postoperative significant TR

TR recurrence rate

De Vega's vs. Pericardial strip annuloplasty

Overall survival
34 (11.1%) of patients had significant TR on discharge from the hospital. The study reported that TR improved in the patient group who had pericardial strip. However, it worsened in the group with De Vega's suture repair (P = 0.05)

Recurrence-free survival was better with pericardial strip annuloplasty compared with that of De Vega's suture repair 86.8 and 71.9%, respectively (P = 0.039)
The number of subjects is a limiting factor. The study
 
Ghanta et al. (2007), J Thorac Cardiovasc Surg, Boston [15]

Retrospective cohort study
(level 3)
January 1999 to December 2003, 237 patients underwent tricuspid annuloplasty. Suture bicuspidization was performed in 157 (66%) and ring annuloplasty in 80 (34%)

Mean follow-up was 3 years
CPB and aortic cross-clamp time




Mortality




Functional improvement



Durability of repair
CPB and cross-clamp time were shorter by 27 min (P = 0.02) and 17 min (P = 0.07), respectively, in bicuspidization patients

Insignificant difference in early and late mortality between the two groups at 3 years follow-up

Similar improvement in the NYHA class between the two groups

No statistical differences in the mean TR grade or prevalence in TR between the two groups at follow-up
Both bicuspidization and ring annuloplasty produce an effective, durable repair at 3 years. postoperatively

Mean follow-up was short

Median time of echocardiographic assessment was 1 year (Q1, 1 week; Q3, 1.5 years). This renders the meaningful follow-up for the assessment of recurrent TR even shorter
 
 
Carrier et al. (2004), J Heart Valve Dis, Canada [16]

Prospective cohort study
(level 3)
Between 1976 and 2002, 463 patients underwent 478 tricuspid annuloplasty procedures. 107 patients (23%) underwent De Vega's semi-circular annuloplasty, 267 (58%) underwent the Bex flexible linear reducer and 89 (19%) Carpentier–Edwards ring annuloplasty Survival





Repair failure
Survival at 5 years was similar between De Vega's and Carpentier–Edwards ring annuloplasty (82 ± 4 and 88 ± 4%, respectively)

Freedom from repair failure was also similar between De Vega's and Carpentier–Edwards ring annuloplasty (95 ± 3 and 94 ± 3%, respectively)
All three techniques resulted in a low rate of failure and good patient survival
 
 
Morishita et al. (2002), J Cardiovasc Surg, Japan [17]

Retrospective cohort study
(level 3)
408 patients underwent De Vega's tricuspid annuloplasty for TR between 1980 and 1999

Mean follow-up was 15 years
De Vega's annuloplasty long-term outcome The 15-year freedom rate from reoperation was 91.6%. The study concluded that De Vega's annuloplasty was an effective and reliable procedure for the treatment of TR Lack of the comparison group was a major limiting factor. However, the study highlights that De Vega's annuloplasty is a relatively cheap and reliable technique

RESULTS

Moderate and severe TR is associated with poor short- and long-term survival [2].

In the past few years, the treatment options for TR have ranged from conservative management to valve replacement and repair. However, recently, the management of TR has evolved in many ways shoulder to shoulder with the management of mitral incompetence, that is, from plication to suture-based annuloplasty to valve replacements and finally to state of the art ring-based repairs. Ring-based repairs are advantageous compared with the other mentioned techniques, since, theoretically, the artificial ring takes tension away from the suture line and prevents recurrent dilatation [3]. Hence, many studies now suggest an improved outcome with ring-based repairs over the conventional suture tricuspid annuloplasty [37].

It is well known that residual TR after surgical repair can lead to biventricular failure, death or reoperation [8], and therefore, the choice of repair is dictated predominantly by the recurrence rate of the procedure. The reported recurrence rates with De Vega's annuloplasty appear to be higher compared with ring repair [2, 46, 912]. However, the only available randomized control trial on this issue is almost two decades old, when diagnosis of TR and its severity, both preoperatively and after, was on clinical grounds [13].

Studies supporting ring annuloplasty as a treatment of choice for TR

Bernal et al. [2] performed a retrospective cohort study with a 15-year follow-up. One hundred and fifty-three patients had undergone combined tricuspid and mitral valve repair surgery. Thirty-eight (20.4%) patients required reoperation for tricuspid valve (TV) dysfunction. The lack of application of an artificial ring was identified as a predictor for reoperation in this study. Ghoreishi et al. [9] performed a prospective cohort study of 101 consecutive patients who had undergone TV repair for TR with an annuloplasty ring. Freedom from more than moderate TR post-ring annuloplasty on discharge was as high as 97%. In a larger study, Navia et al. [10] studied a cohort of 2277 patients who had undergone TV procedures for TR. By the 5-year follow-up with transthoracic echocardiography, the patients who had undergone ring annuloplasty had the least TR recurrence compared with other techniques.

Basel et al. [12] performed a study of 129 patients undergoing annuloplasty for TR. Of this group, 67 had undergone ring annuloplasty and the remaining 62 patients had undergone De Vega's annuloplasty. The study concluded that ring annuloplasty has a significantly lower TR recurrent rate.

In our literature search, we only found one randomized controlled trial (RCT) with regard to the subject. This was performed by Rivera et al. [6] in 1985. One hundred and fifty-nine patients who had undergone TV repair for moderate to severe TR had been randomized, of which 76 patients had undergone ring annuloplasty and 83 De Vega's suture repair. The study concluded on the 5-year follow-up that the rate of TR was significantly higher with De Vega's suture repair compared with ring annuloplasty.

Matsuyama et al. [13] and Chang et al. [14] both also supported the above findings. However, the latter study compared pericardial strip annuloplasty with De Vega's suture annuloplasty.

Studies not supporting ring annuloplasty as treatment of choice for TR

Giamberti et al. [3], in a cohort of 65 patients who had undergone TR repair using suture annuloplasty (n = 48) and TV ring (n = 14), reported no significant difference in outcome between the two techniques on a 5-year follow-up. Moreover, Sarralde et al. [11] performed a retrospective cohort study of 299 patients who had undergone TV repair with a mean follow-up of 16.4 years. This study reported better results with the conventional De Vega's suture annuloplasty compared with ring annuloplasty.

Tang et al. [3], Ghanta et al. [15], McCarthy et al. [5] and Carrier et al. [16] found no statistically significant difference between the two techniques of ring annuloplasty and De Vega's annuloplasty.

Morishita et al. [17] reported in their cohort of 408 patients undergoing De Vega's annuloplasty that this is a safe and effective method of TR repair.

An important shortcoming central to almost all reported series is a non-standardized selection criterion for the repair technique that was based solely on the surgeon's discretion. This bias can only be overcome by a randomized trial, and it is unfortunate that none relevant to the current era is available.

A higher incidence of low cardiac output has been reported with ring annuloplasty [4]. We presume that this may arise as a consequence of a longer aortic cross-clamp time [3, 4] and bypass time [35]. In addition, a ring-based TV repair may be rendered less desirable by the relative inexpensiveness of a suture annuloplasty.

CLINICAL BOTTOM LINE

We conclude that there is good evidence to support ring annuloplasty over De Vega's annuloplasty. Multiple recent cohort studies support the use of ring annuloplasty for moderate to severe TR over De Vega's annuloplasty both in terms of the rate of recurrence of TR leading to reoperation and long-term mortality.

Conflict of interest: none declared.

References

  • 1.Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg. 2003;2:405–9. doi: 10.1016/S1569-9293(03)00191-9. [DOI] [PubMed] [Google Scholar]
  • 2.Bernal JM, Ponton A, Diaz B, Llorca J, Garcia I, Sarralde A, et al. Combined mitral and tricuspid valve repair in rheumatic valve disease: fewer reoperations with prosthetic ring annuloplasty. Circulation. 2010;121:1934–40. doi: 10.1161/CIRCULATIONAHA.109.894873. [DOI] [PubMed] [Google Scholar]
  • 3.Giamberti A, Chessa M, Ballotta A, Varrica A, Agnetti A, Frigiola A, et al. Functional tricuspid valve regurgitation in adults with congenital heart disease: an emerging problem. J Heart Valve Dis. 2011;20:565–70. [PubMed] [Google Scholar]
  • 4.Tang GHL, David TE, Sing SK, Maganti MD, Amstrong S, Borger MA. Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes. Circulation. 2006;114(Suppl. I):I-577–81. doi: 10.1161/CIRCULATIONAHA.105.001263. [DOI] [PubMed] [Google Scholar]
  • 5.McCarthy PM, Bhudia SK, Rajeswaran J, Hoercher KJ, Lytle BW, Cosgrove DM, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004;127:674–85. doi: 10.1016/j.jtcvs.2003.11.019. [DOI] [PubMed] [Google Scholar]
  • 6.Rivera R, Duran E, Ajuria M. Carpentier's flexible ring versus De Vega's annuloplasty. A prospective randomized study. J Thorac Cardiovasc Surg. 1985;89:196–203. [PubMed] [Google Scholar]
  • 7.Panos A, Myers PO, Kalangos A. Thoracoscopic and robotic tricuspid valve annuloplasty with biodegradable ring: an initial experience. J Heart Valve Surg. 2010;19:201–5. [PubMed] [Google Scholar]
  • 8.Ruel M, Rubens FD, Masters RG, Pipe Al, Bedard P, Mesana TG. Late incidence of persistent or recurrent heart failure in patients with mitral prosthetic valves. J Thorac Cardiovasc Surg. 2004;128:278–83. doi: 10.1016/j.jtcvs.2003.11.048. [DOI] [PubMed] [Google Scholar]
  • 9.Ghoreishi M, Brown JM, Stauffer CE, Young CA, Byron MJ, Griffith BP, et al. Undersized tricuspid annuloplasty rings optimally treat functional tricuspid regurgitation. Ann Thorac Surg. 2011;92:89–96. doi: 10.1016/j.athoracsur.2011.03.024. [DOI] [PubMed] [Google Scholar]
  • 10.Navia JL, Nowicki ER, Blackstone EH, Brozzi NA, Nento DE, Atik FA, et al. Surgical management of secondary tricuspid valve regurgitation: annulus commissure, or leaflet procedure. J Thorac Cardiovasc Surg. 2010;139:1473–82. doi: 10.1016/j.jtcvs.2010.02.046. [DOI] [PubMed] [Google Scholar]
  • 11.Sarralde JA, Bernal JM, Llorca J, Ponton A, Diez-Solorzano L, Gimenez-Rico JR, et al. Repair of rheumatic tricuspid valve disease: predictors of very long-term mortality and reoperation. Ann Thorac Surg. 2010;90:503–8. doi: 10.1016/j.athoracsur.2010.03.105. [DOI] [PubMed] [Google Scholar]
  • 12.Basel H, Aydin U, Kutlu H, Dostbil A, Karadag M, Odabasi D, et al. Outcomes of De Vega versus biodegradable ring annuloplasty in the surgical treatment of tricuspid regurgitation (mid-term results) Heart Surg Forum. 2010;13:233–7. doi: 10.1532/HSF98.20091170. [DOI] [PubMed] [Google Scholar]
  • 13.Matsuyama K, Matsumoto M, Sugita T, Nishizawa J, Tokuda Y, Matsuo T, et al. De Vega annuloplasty and Carpentier-Edwards ring annuloplasty for secondary tricuspid regurgitation. J Heart Valve Dis. 2001;10:520–4. [PubMed] [Google Scholar]
  • 14.Chang BC, Song SW, Lee S, Yoo KJ, Kang MS, Chung N. Eight-year outcomes of tricuspid annuloplasty using autologous pericardial strip for functional tricuspid regurgitation. Ann Thorac Surg. 2008;86:1485–92. doi: 10.1016/j.athoracsur.2008.07.007. [DOI] [PubMed] [Google Scholar]
  • 15.Ghanta RK, Chen R, Narayanasamy N, McGurk S, Lipsitz S, Chen FY, et al. Suture bicuspidization of the tricuspid valve versus ring annuloplasty for repair of functional tricuspid regurgitation: midterm results of 237 consecutive patients. J Thorac Cardiovasc Surg. 2007;133:117–26. doi: 10.1016/j.jtcvs.2006.08.068. [DOI] [PubMed] [Google Scholar]
  • 16.Carrier M, Pellerin M, Guertin MC, Bouchard D, Hebert Y, Perrault LP, et al. Twenty-five years’ clinical experience with repair of tricuspid insufficiency. J Heart Valve Dis. 2004;13:952–6. [PubMed] [Google Scholar]
  • 17.Morishita A, Kitamura M, Noji S, Aomi S, Endo M, Koyanagi H. Long-term results after De Vega's tricuspid annuloplasty. J Cardiovasc Surg. 2002;43:773–7. [PubMed] [Google Scholar]

Articles from Interactive Cardiovascular and Thoracic Surgery are provided here courtesy of Oxford University Press

RESOURCES